STI-powered program allows patients, physicians and pharmacists to
choose to stay with brand
HALIFAX, Jan. 24, 2012 /CNW/ - Canadian pharmaceutical manufacturers,
Bristol-Myers Squibb Canada and Sanofi Canada, have introduced a
Patient Benefit Program providing healthcare professionals the ability
to choose to keep patients on brand Plavix® by covering the difference in cost between generic clopidogrel and brand
Bristol-Myers Squib Canada and Sanofi Canada engaged Halifax-based, STI
Technologies Limited to develop a solution to help their patients stay
on the trusted brand Plavix®, as generic alternatives are being introduced into Canada.
"If a physician feels their patient would be best served by being
prescribed branded Plavix® instead of generic clopidogrel, this program allows them to do so
without an additional cost to the patient, the healthcare system or to
private insurers," says Dr. Michael Love, Cardiologist & President of
the Canadian Association of Interventional Cardiology. "The most
important thing is the ability to choose the best course of therapy,
solely based on what is in the best interest of the patient."
Coincident with the introduction of generics into the Canadian market,
STI worked with the two manufacturers to deliver and rollout the
national program, providing continuity of care for those patients who
are prescribed brand Plavix®.
"Many patients rely on Plavix®," says Steve Nicolle, CEO at STI. "So to help broaden access to the
program, patient benefit cards are available online (www.plavixsupport.ca) and from physicians as well as local retail pharmacies."
The Plavix® Patient Benefit Program is currently available nationally in Canada,
except the provinces of Quebec and Manitoba, and must be accompanied by
a prescription for brand Plavix®.
About STI Technologies Limited
Back in 2001, on a napkin at a local diner, three pharmaceutical
marketers had one innovative idea. There must be a better way.
A simple idea - bridge the four distinct worlds of pharma, physicians,
patients and pharmacy with one little card.
First, we revolutionized the way pharmaceutical companies sample their
medications, by involving pharmacy.
Then, we invented new marketing solutions - empowering physicians and
patients with choice and affordable access to medication. All with
Now, STI is way more than just a card. Our technology, solutions, and
people have made us the largest transactional marketing company in
Canada. Innovative ideas come from Halifax, Nova Scotia.
Image with caption: "Plavix® Prescription Benefit Card (CNW Group/STI Technologies Inc.)". Image available at: http://photos.newswire.ca/images/download/20120124_C6178_PHOTO_EN_9124.jpg
Image with caption: "Plavix® Prescription Benefit eCard (CNW Group/STI Technologies Inc.)". Image available at: http://photos.newswire.ca/images/download/20120124_C6178_PHOTO_EN_9125.jpg
SOURCE STI Technologies Inc.
For further information:
For questions or more information on the Plavix® Patient Benefit Program please contact STI customer service at CustomerService@smartsti.com or 1-877-790-1991.
Mary Jane Leslie, Marketing Associate, STI